Science
Cancer Pharmacology

Cancer Pharmacology is the study of the effects and mechanisms of drugs used in the treatment of cancer. This research aims to improve the safety and efficacy of cancer treatments by developing new and innovative drugs, as well as optimizing existing ones. Cancer pharmacologists work to understand the molecular and cellular targets of cancer drugs, how drugs interact with these targets, and how these interactions impact the efficacy and toxicity of treatments. This research also involves studying how drugs are metabolized in the body, and how individual patient factors, such as genetics and underlying medical conditions, can affect drug response. At CRTOH, Cancer Pharmacology research is focused on developing personalized and effective treatments, improving patient outcomes and advancing the field of cancer research.
Our researchers
Grid view
-
Prof. Carole Bourquin
-
Prof. Muriel Cuendet
School of pharmaceutical sciences,Faculty of Science
E-mail
-
Prof. Vladimir Katanaev
Oncogenic signaling pathways: from fundamental research to drug discovery, Group leader
-
Prof. Francesco Luigi Gervasio
Biological and Pharmaceutical Modelling, School of Pharmaceutical Sciences
Prof. Francesco Luigi Gervasio
B09.1716.A
022 379 4242
E-mail
-
Prof. Patrycja Nowak-Sliwinska
-
-
List view
-
Bourquin Carole
Immunopharmacology of Cancer, Group leader
-
Cuendet Muriel
Pharmacognosy Group leader, CRTOH associate member
School of pharmaceutical sciences,Faculty of Science -
Katanaev Vladimir
Oncogenic signaling pathways: from fundamental research to drug discovery, Group leader
-
Gervasio Francesco Luigi
Biological and Pharmaceutical Modelling, School of Pharmaceutical Sciences
B09.1716.A -
Nowak-Sliwinska Patrycja
Molecular Pharmacology, Group leader
-
Serre-Beinier Véronique
Head of Division / Biologist
D02.1547.A -
Tamburini Jérôme
Lymphomas and leukaemias, Group Leader